TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 48 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $123,000 | – | 77,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Murchinson Ltd. | 500,005 | $5,050,000 | 0.97% |
| GSA CAPITAL PARTNERS LLP | 50,800 | $80,000 | 0.01% |
| XTX Topco Ltd | 18,596 | $29,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 450,696 | $712,000 | 0.00% |
| Renaissance Technologies | 643,124 | $1,016,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 30,454 | $48,000 | 0.00% |
| Federation des caisses Desjardins du Quebec | 158 | $250 | 0.00% |
| FMR LLC | 2,131 | $3,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,810 | $20,000 | 0.00% |
| Focused Wealth Management, Inc | 22 | $0 | 0.00% |